Clinical Study
Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival
Table 1
Baseline characteristics of the patient cohort.
| | Variable | Response | No response | value |
| | Number of patients | 65 (54%) | 54 (45%) | | | Age, median (IQR) | 56 51–62 | 59 50.5–63 | 0.325 | | Age range | 25–78 | 25–74 | | | Gender (m/f) | 44/21 | 37/17 | 0.580 | | Etiology, # | | | | | Alcohol abuse | 46 | 31 | 0.130 | | Hepatitis B | 0 | 3 | 0.055 | | Hepatitis C | 3 | 6 | 0.184 | | AIH | 1 | 0 | 0.362 | | Hemochromatosis | 3 | 1 | 0.407 | | PBC/PSC | 2 | 5 | 0.155 | | Cryptogenic | 11 | 9 | 0.970 | | Child stage, | | | 0.693 | | A | 20 | 8 | 0.042 | | B | 20 | 30 | 0.007 | | C | 25 | 16 | 0.404 | | MELD score, median (IQR) | 26 19–32 | 26 21–33 | 0.505 |
|
|
#: more than one etiology possible.
|
